APA

Lai F., Guo S. T., Jin L., Jiang C. C., Wang C. Y., Croft A., Chi M. N., Tseng H., Farrelly M., Atmadibrata B., Norman J., Liu T., Hersey P. & Zhang X. D. (20140225). Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3. : Cell death & disease.

Chicago

Lai F, Guo S T, Jin L, Jiang C C, Wang C Y, Croft A, Chi M N, Tseng H-Y, Farrelly M, Atmadibrata B, Norman J, Liu T, Hersey P and Zhang X D. 20140225. Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3. : Cell death & disease.

Harvard

Lai F., Guo S. T., Jin L., Jiang C. C., Wang C. Y., Croft A., Chi M. N., Tseng H., Farrelly M., Atmadibrata B., Norman J., Liu T., Hersey P. and Zhang X. D. (20140225). Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3. : Cell death & disease.

MLA

Lai F, Guo S T, Jin L, Jiang C C, Wang C Y, Croft A, Chi M N, Tseng H-Y, Farrelly M, Atmadibrata B, Norman J, Liu T, Hersey P and Zhang X D. Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3. : Cell death & disease. 20140225.